Oxcarbazepine is an anti-seizure medication FDA-approved to treat partial-onset seizures in adults and children. Sold under the brand name Trileptal, it works by calming overactive electrical signals in the brain. Beyond epilepsy, doctors also prescribe it off-label for conditions like bipolar disorder and a type of facial nerve pain called trigeminal neuralgia.
Partial-Onset Seizures: The Primary Use
Partial-onset seizures (also called focal seizures) start in one area of the brain rather than both sides at once. They can cause involuntary movements, unusual sensations, or brief episodes of confusion. Some partial-onset seizures spread to become full-body convulsions. Oxcarbazepine is approved to treat these seizures either on its own (monotherapy) or alongside other seizure medications (adjunctive therapy).
For adults, it can be used in both roles. For children aged 4 and older, it’s approved as a standalone treatment. Children as young as 2 can take it when it’s added to another seizure medication they’re already on. Adults typically start at 600 mg per day, split into two doses. The standard maintenance dose for add-on therapy is 1,200 mg per day, though some people on monotherapy may need up to 2,400 mg per day.
How Oxcarbazepine Works
The medication blocks voltage-sensitive sodium channels on nerve cells. These channels normally allow electrical impulses to fire and travel between neurons. In epilepsy, some nerve cells become hyperexcited, firing too rapidly and triggering seizures. By blocking these channels, oxcarbazepine stabilizes those overactive neurons, reduces repetitive firing, and limits the spread of abnormal electrical signals through the brain. This same mechanism likely explains why it’s useful for nerve pain and mood instability, since both involve disrupted electrical signaling in the nervous system.
Off-Label Uses
Bipolar Disorder
Oxcarbazepine is sometimes prescribed for bipolar disorder, particularly for people who haven’t responded well to first-line mood stabilizers. It is not FDA-approved for this purpose, but its ability to calm excessive nerve activity can help stabilize mood swings. Stopping it suddenly in someone with bipolar disorder may trigger a relapse, so any dose changes need to happen gradually.
Trigeminal Neuralgia
Trigeminal neuralgia causes sudden, severe facial pain along the trigeminal nerve, often described as electric shocks. This condition is especially common in people with multiple sclerosis. Oxcarbazepine is used off-label for these patients and is closely related to carbamazepine, which has long been a standard treatment for trigeminal neuralgia.
Other Neuropathic Pain
Some clinicians have tried oxcarbazepine for broader types of nerve pain, including diabetic neuropathy and pain from pinched nerves (radiculopathy). However, the evidence here is weak. Reviews of clinical studies have found little support for its effectiveness in these conditions, so it’s not a go-to option for general nerve pain.
Less Common Uses
Small studies have explored oxcarbazepine for Sydenham chorea, a movement disorder in children that causes involuntary jerking. In a case series of four children aged 8 to 13, symptoms improved by more than 50% after the first dose and fully resolved within a week at higher doses. Researchers have also looked at it for behavioral problems following brain injuries, particularly in children with frontal-lobe damage who display irritability. About half the patients in one retrospective study showed improvement.
How It Compares to Carbamazepine
Oxcarbazepine was developed as a successor to carbamazepine, and the two medications work in similar ways. The key differences come down to side effects and tolerability. In studies comparing the two in children with partial seizures, the most common side effects of oxcarbazepine were fatigue and headache, while carbamazepine more often caused fatigue and rash. Carbamazepine is also more likely to cause changes in brain wave patterns visible on an EEG. For many patients, oxcarbazepine is chosen because it tends to be better tolerated while offering similar seizure control.
Low Sodium Levels: A Key Risk
The most distinctive side effect of oxcarbazepine is hyponatremia, a drop in blood sodium levels. This is far more common than many people realize. In one study published in Neurology, nearly 30% of patients on oxcarbazepine developed sodium levels below normal. About 12% experienced severe drops, which can cause symptoms like nausea, headache, confusion, and in extreme cases, seizures (ironically). Doctors typically monitor sodium levels with blood tests during the first few months of treatment and periodically afterward, especially in older adults or anyone taking water pills.
Serious Skin Reactions
Rarely, oxcarbazepine can trigger severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. These are potentially life-threatening conditions involving widespread blistering and skin peeling. The risk is highest in people who carry certain genetic markers. Individuals of Han Chinese, Hong Kong Chinese, or Thai descent should be screened for the HLA-B*1502 gene variant before starting treatment, as this variant significantly increases the risk. For people of European or Japanese descent, a different variant called HLA-A*3101 may also raise the risk, and testing can help guide the decision.
If you develop a rash, blistering, or mouth sores while taking oxcarbazepine, that warrants immediate medical attention.
Effects on Birth Control and Pregnancy
Oxcarbazepine speeds up the liver’s breakdown of hormonal birth control, including pills, patches, and rings. This can reduce their effectiveness enough to cause breakthrough bleeding or unintended pregnancy. If you rely on hormonal contraception, you’ll need to discuss alternative or additional methods with your provider.
During pregnancy, oxcarbazepine carries its own concerns. Data from a large Nordic registry study found that 15.2% of babies exposed to oxcarbazepine in the womb were born small for gestational age, compared to 10.9% of babies born to women with epilepsy who weren’t on any seizure medication. That’s a meaningful difference, though stopping seizure medication during pregnancy also carries serious risks. For women with epilepsy who are pregnant or planning to become pregnant, this is a decision that involves carefully weighing the seizure risk against potential effects on the baby.